ITC Rules Apple Watches Do Not Infringe Masimo Patents

A U.S. trade judge ruled that Apple's redesigned smartwatches do not violate Masimo's blood-oxygen patents. The decision rejects a bid for a new import ban.

Xurve View
洞察:

A trade tribunal in the United States has issued a preliminary ruling in favor of Apple Inc., finding that the company's current smartwatch models do not infringe on patents held by Masimo Corporation. This decision rejects a bid for a renewed import ban on the devices, following a long-standing legal battle over medical-monitoring technology. Apple previously modified its watches to bypass an import ban issued by the International Trade Commission (ITC) in 2023, and an ITC judge has now agreed that these redesigned versions do not violate Masimo's patent rights.

A customer uses an iPhone to photograph a new Apple Watch at a retail location in Paris, France, in April 2015. REUTERS/Christian Hartmann/File Photo
IUX24

IUX24 提供深度財經、經濟與投資資訊,藉助 AI 發掘全球市場中最重要的信號。

IFZA Properties, Dubai Silicon Oasis, DSO-IFZA, Dubai, United Arab Emirates

Copyright IUX24 MEDIA - FZCO. 版權所有。

由 AI 驅動 • 精益求精

IUX24 是一個資訊與分析平台,提供新聞、市場數據、分析工具及 AI 驅動的功能,僅供資訊參考與教育用途。所提供的服務和資訊不構成投資建議、交易信號或經紀服務。投資涉及風險,用戶在作出投資決定前應審慎評估相關資訊。